🇺🇸 FDA
Pipeline program

Placebo, Velcade and dexamethasone

CR017743

Phase 3 small_molecule terminated

Quick answer

Placebo, Velcade and dexamethasone for Multiple Myeloma is a Phase 3 program (small_molecule) at Centocor B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Centocor B.V.
Indication
Multiple Myeloma
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials